Read the text of this document (8 pages)
Children, Families, Health & Care Select Committee
Review Scoping Report – 2026/2027
A Review of Pharmacies and Pharmacy First in
Hillingdon
1. OBJECTIVES
Aim of the review
At its meeting on 23 June 2026, the Children, Families, Health and Care Select Committee
elected to undertake a major review of pharmacies and the Pharmacy First service in
Hillingdon. This review aims to look at the services provided by pharmacies to alleviate the
pressure on primary care, including the Pharmacy First initiative, to understand the
contribution pharmacies make to the wider health and care system in Hillingdon and identify
opportunities to s trengthen partnership working and maximise the benefits of pharmacy
services for residents.
Terms of Reference
The following Terms of Reference are suggested for the review, subject to any changes
agreed by the Committee:
1. to gain a n understanding of the services currently provided by pharmacies in
Hillingdon;
2. to understand how pharmacy services are commissioned and by which organisations;
3. to review the current availability of support for pharmacies;
4. to establish what services have already been commi ssioned from pharmacies to
alleviate pressure on primary care and identify how successful th ese services have
been in achieving this objective;
5. to explore the possibility of pharmacies providing additional services to alleviate the
pressure on primary care; and
6. subject to the Committee’s findings, to draw conclusions, propose actions and make
service and policy recommendations to the decision-making Cabinet (which may then
refer formally to a relevant external body).
2. BACKGROUND
Context and Key Information
Pharmacies (also known as chemists) are healthcare facilities where medicinal drugs are
prepared, dispensed and sold. These establishments serve as crucial points of access for
individuals seeking medications, health advice and various pharma ceutical services.
Managed by licensed pharmacists, pharmacies ensure the safe and effective use of
medication, adhering to regulatory standards and professional guidelines.
Healthcare commissioning is the process by which the health needs of a populatio n are
assessed, the responsibility is taken for ensuring that appropriate services are available to
meet these needs and the accountability for the associated health outcomes is established.
Since April 2013, a number of commissioners have had a role in commissioning services from
community pharmacies. The following general rules apply, but there are grey areas which
may result in local variation on which commissioner takes a lead in commissioning a service:
Local NHS England teams - commission all services in the NHS Community Pharmacy
Contractual Framework (CPCF), i.e. Essential, Advanced and Enhanced Services. Other
commissioners cannot commission these services from community pharmacies.
Enhanced Services are those pharmaceutical services that are listed in The
Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013.
Other commissioners may choose to commission some of these Enhanced Services from
community pharmacies, but they would be classed as locally commissioned services and
not Enhanced Services.
Integrated Care Boards (ICBs) - the services that the ICB commissions include planned
hospital care, rehabilitative care, urgent and emergency care (including out -of-hours and
accident and emergency services), most community health services, maternity services,
mental health and learning disability services. From community pharmacy, ICBs may wish
to commission services such as minor ailments services and palliative care schemes.
Local Authorities (LAs) - have responsibility for commissioning a wide range of services,
including most public health services and social care services. The following public health
services provided by community pharmacies would be commissioned by local authorities:
Supervised consumption;
Needle and syringe programme;
NHS Health Check;
EHC and contraceptive services;
Sexual health screening services;
Stop smoking;
Chlamydia testing and treatment;
Weight management; and
Alcohol screening and brief interventions.
LAs will use their own contracts or the standard public health contract to commission
services from community pharmacies. There are a small number of circumstances where
a public health service is commissioned by another organisation, e.g. NHS England
commissions vaccination services from GPs, community pharmacies and other providers.
There may also be circumstances where ICBs may wish to be involved in commissioning
a public health service, due to the impact the service may have on the development or
management of long-term conditions. This may involve co-commissioning a service, which
is likely to happen on a more regular basis as a resu lt of the full introduction of the Better
Care Fund in 2015/16.
Community Pharmacy England believes that some public health services (which are widely
commissioned at a local level ) could be more effectively and efficiently commissioned
within the national Community Pharmacy Contractual Framework (CPCF). However, the
Government’s localisation agenda and the current commissioning landscape, where NHS
England commissions the CPCF but LAs hold funds for public health services, means that
it is unlikely that such services could be commissioned via the national CPCF in the near
future.
Whilst the Council commissions a number of public health services delivered through
community pharmacies, Pharmacy First is a nationally commissioned NHS service. The
Council’s Children, Families, Health and Care Select Committee will consider how local
partners can work together to maximise the benefits of the service for Hillingdon residents.
What Services are Provided at Pharmacies?
Pharmacies offer a wide range of services beyond the mere dispensing of medications. Key
services include:
Prescription Dispensing: Preparing and providing prescribed medications to patients.
Over-the-Counter (OTC) Sales: Supplying non -prescription medications and health
products.
Health Advice and Consultations: Providing guidance on the safe use of medications,
managing minor ailments and preventive health measures.
Vaccinations: Administering immunisations for flu, COVID -19 and other preventable
diseases.
New Medicine Service (NMS) : providing support for people with specific l ong-term
conditions newly prescribed a medicine to help improve medicines adherence
Health Screenings: Offering services such as blood pressure monitoring, cholesterol
checks and diabetes screenings.
Pharmacy Contraception Service (PCS):
o Providing initiation and on-going supply of oral contraceptives, and
o Free access to emergency contraception pills; and
Smoking Cessation Programmes: Supporting individuals in their efforts to quit smoking
through counselling and nicotine replacement therapies.
The cost of commissioning pharmacies can vary significantly based on the scope of services
provided, the geographical location and the contractual agreements in place. In the UK, the
NHS allocates a substantial budget to community pharmacies, covering dispensing fees,
service payments and additional reimbursements for specific health programmes . Precise
financial figures are often determined through detailed budget planning and negotiations
between healthcare authorities and pharmacy representatives.
What is the Local Pharmaceutical Committee (LPC)?
The local organisation for community pharmacy is the Local Pharmaceutical Committee (LPC)
– there are around 55 LPCs throughout England. The LPC is the focus for all community
pharmacists and community pharmacy owners and is an independent and representative
group. The LPC works locally with NHS England Area Teams, ICBs, local authorities and
other healthcare professionals to help plan healthcare services.
The LPC negotiates and discusses pharmacy services with commissioners and is available
to give advice to community pharmacy contractors and ot hers wanting to know more about
local pharmacy. LPCs liaise closely with their medical equivalent the Local Medical
Committees (LMCs) so that GPs and pharmacists can work together to deliver services to
patients. LPCs also work closely with Local Dental Committees (LDCs) and Local Optical
Committees (LOCs).
What is a Pharmaceutical Needs Assessment?
Pharmaceutical Needs Assessments (PNAs) have been in place for 20+ years and provide a
comprehensive evaluation process that determines the local needs for pharmaceutical
services within a specific area or population. It aims to ensure that the provision of these
services aligns with the healthcare needs of the community. PNAs are particularly crucial for
healthcare planners, policymakers and service providers as they help in the strategic planning
and development of pharmacy services, ensuring that resources are utili sed effectively and
efficiently.
One of the primary objectives of a PNA is to identify gaps in existing pharmaceutical services.
This involv es assessing the availability, accessibility and quality of current services and
determining whether they meet the population's needs. By highlighting these gaps, PNAs
provide a foundation for developing strategies to address unmet needs, improve service
delivery and enhance patient outcomes. It should be noted that a gap in existing
pharmaceutical services was identified some time ago in the Heathrow Villages as, although
geographically close, the pharmacies located in the airport terminals are not acces sible for
residents.
A PNA serves as an essential tool for healthcare commissioners and providers, guiding the
development and commissioning of new services or the modification of existing ones. It
ensures that decisions are evidence -based, taking into account the specific needs of the
population, demographic changes and emerging health trends. This targeted approach helps
in optimising resource allocation and improving the overall efficiency of healthcare delivery.
Hillingdon’s current PNA can be foun d at: https://pre.hillingdon.gov.uk/strategies-policies-
projects/needs-assessments.
How Do Pharmacies Alleviate Pressure On Primary Care And What Else Could Be Done
Pharmacies play a critical role in alleviating demand pressures on primary care by:
Managing Minor Ailments: Providing treatment and advice for minor health issues,
reducing the need for GP consultations.
Offering Preventive Services: Administering vaccinations and health screenings,
thereby preventing more serious health issues that would require GP intervention.
Medication Management: Conducting medication r eviews and ensuring proper
medication use, thus preventing complications that might necessitate a GP visit.
Health Education: Educating the public on health maintenance and disease
prevention, which helps reduce the incidence of illnesses that would burden GPs.
Pharmacy First
The Pharmacy First service builds on the NHS Community Pharmacist Consultation Service
which started in October 2019. The consultation service enabled patients to be referred into
community pharmacy for a minor illness or an urgent repeat medicine supply. The new
Pharmacy First service was launched on 31 January 2024 and adds to the existing
consultation service. It enables community pharmacies to complete episodes of care for 7
common conditions following defined clinical pathways.
In May 2023, NHS England and the Department of Health and Social Care announced a
Delivery plan for recovering access to primary care. Part of the plan include enabling patients
to get certain prescription medications directly from a pharmacy, without a GP appointment.
It was anticipated that t his new service would free up GP appointments for patients who
needed them most and would give people quicker and more convenient access to safe and
high-quality healthcare. It include d the supply of appropriate medicines for 7 common
conditions including earache, sore throat, and urinary tract infections, aiming to address
health issues before they got worse. It is anticipated that this will also reduce the number of
residents presenting at Hillingdon Hospital ’s Accident and Emergency / Urgent Treatment
Centre when they could have been seen by the Pharmacy First service or a GP.
The Pharmacy First initiative was launched to make greater use of community pharmacists’
skills and opportunities to engage patients and ensure patients receive the right treatment at
the right time. As part of the initiative, pharmacists can help patients to manage the following
seven conditions where not complex across various age ranges (patients outside these age
ranges should consult their GP for treatment):
Earache: Ages 1 to 17 years
Impetigo: Ages 1 year and over
Infected insect bites: Ages 1 year and over
Shingles: Ages 18 years and over
Sinusitis: Ages 12 years and over
Sore throat: Ages 5 years and over
Uncomplicated urinary tract infections (UTIs) in women: Ages 16 to 64 years
Patients can access the Pharmacy First service by attending or contacting the pharmacy
directly without the need for referral (although they can also be referred by other organisations
including general practice, urgent and emergency care settings, and NHS 111 (online and via
telephone)). Pharmacies have private consultation rooms that can be used for consultations
with patients, and pharmacists can see patients for clinical services without always needing
an appointment. After a consultation with the pharmacist, the pharmacy will send a
notification to the patient’s GP on the same day or on the following working day.
Pharmacies have the potential to further reduce the demand pressure on GPs by expanding
their scope of services. Potential areas for enhancement include:
Chronic Disease Management: Taking on a greater role in managing chronic
conditions such as diabetes, hypertension and asthma through regular monitoring and
patient education.
Advanced Clinical Services: Providing more advanced clinical services such as minor
injury treatment, thus diverting cases that do not require a GP's expertise.
Telehealth Services: Implementing telehealth consultations to offer advice and support
remotely, thereby increasing accessibility and convenience for patients.
Collaborative Care Models: Working closely with GPs and other healthcare
professionals to deliver integrated care plans that optimi se patient outcomes and
resource utilisation.
Patient Experience
Community pharmacies play an increasingly important ro le within the local health and care
system, providing accessible healthcare advice, medicines optimisation, and an expanding
range of clinical services closer to where residents live. For many people, pharmacies are
the most accessible point of contact wi th the NHS, often offering timely support without the
need for an appointment. As the role of community pharmacy continues to evolve through
initiatives such as Pharmacy First, it is important that any review considers not only the
contribution pharmacies make to reducing pressure on general practice and urgent care
services, but also the experiences of the residents who rely on them. Understanding whether
residents are aware of the services available, know when it is appropriate to use Pharmacy
First instead of their GP and have confidence in the care provided will be essential to
assessing the effectiveness of the service.
Consideration needs to be given to potential barriers, including opening hours, transport,
digital exclusion, language, disability , consultation privacy and awareness of the services
offered by individual pharmacies. Previous resident feedback has highlighted issues relating
to communication between GP practices and pharmacies, repeat prescriptions, medicine
shortages, variations in commissioned services and a lack of clear information about which
pharmacies provide specific services. The review therefore presents an opportunity to
understand the local implementation and impact of Pharmacy First by examining service
activity, referral pathways and residents' experiences, rather than assuming its effectiveness.
Engaging with a broad range of stakeholders (including Pharmacy First users and non-users,
community pharmacists, GP practice representatives and voluntary and community
organisations) could provide a more comprehensive understanding of how pharmacy services
are experienced in practice and whether they are meeting the needs of all residents
consistently and equitably.
Executive Responsibilities
The portfolio Cabinet Member responsible is Councillor Susan O’Brien.
3. EVIDENCE & ENQUIRY
Potential witnesses (including service users)
Witnesses will be identified by the Committee in consultation with relevant officers and may
include:
Service users
Local Pharmaceutical Committee
Community Pharmacists
Voluntary Sector Organisations
West and North London Integrated Care Board
Sharon Stoltz, Director of Public Health, LBH
Dr Ritu Prasad, Chair of The Confederation Hillingdon CIC
Keith Spencer, Managing Director, Hillingdon Health and Care Partners
Samreen Nawshin, Healthwatch Hillingdon
Lines of Enquiry
Lines of enquiry can be expanded as the review progresses or included in relevant witness
session reports. However, lines of enquiry may include:
1. What community pharmacy services are currently commissioned in Hillingdon?
2. How do services provided by pharmacies in Hillingdon alleviate the pressure on
primary care?
3. Are the current pharmacy services being used as well as they could by residents? If
not, how could this be improved?
4. What additional services could be provided by pharmacies to alleviate pressure on
primary care?
5. How is service quality and patient experience monitored across community pharmacy
services and how is learning used to support continuous improvement?
6. How aware are Hillingdon residents of Pharmacy First and other pharmacy services?
7. What is the service user experience in relation to the availability / accessibility of
services?
8. What prevents residents from using pharmacies as a first point of contact?
9. How is the scope of provision geographically located and does this meet the needs of
residents? Are there particular communities or areas of the Borough where pharmacy
access is weaker?
10. Are services available consistently across Hillingdon, including evenin gs and
weekends?
11. How are pharmacy-related complaints, concerns, and patient feedback captured and
acted on?
Surveys, site-visits or other fact-finding events
Such opportunities will be identified as the review progresses.
Future information that may be required
Further information may be identified as the review progresses.
4. REVIEW PLANNING & TIMETABLE
Proposed timeframe and milestones for the review:
Meeting
Date
Action Purpose / theme Witnesses /
officers attending
21 July
2026
Agree Scoping
Report
Information and analysis TBC
13 October
2026
Witness Session
1
Information and analysis Healthwatch
Hillingdon
Service Users
12
November
2026
Witness Session
2
Information and analysis TBC
12 January
2027
Witness Session
3
Information and analysis -
To discuss key findings and
identify potential
recommendations
TBC
Outside the committee – workshop / survey / networking session / consultation / informal
meeting with users, etc...
16 February
2027
Agree
recommendations
To agree recommendations
11 March
2027
Approval of draft
final report
To agree draft final report to
Cabinet
Meeting
Date
Action Purpose / theme Witnesses /
officers attending
29 April
2027
Final report to be
presented to
Cabinet
Resource requirements
The review will be undertaken within existing resources.
Equalities impact
The 2010 Equality Act outlines the provisions of the Public Sector Equalities Duty which
requires Public Bodies to have due regard to the need to:
eliminate unlawful discrimination, harassment and victimisation and other conduct
prohibited by the Equality Act 2010.
advance equality of opportunity between people from different groups.
foster good relations between people from different groups.
The broad purpose of this duty is to integrate considerations of equality into day business and
keep them under review in decision making, the design of policies and the delivery of services.
There are no equality impact issues relating to the matters set out in this report.
Background Papers / further reading
None.
Text extracted automatically from the PDF, so layout, tables and images are not shown. Open the original PDF on LB Hillingdon’s website.